Tag: biomarker discovery outsourcing services market report

  • Comprehensive Biomarker Discovery Outsourcing Services Market Analysis 2024: Size, Share, And Key Trends

    Comprehensive Biomarker Discovery Outsourcing Services Market Analysis 2024: Size, Share, And Key Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Biomarker Discovery Outsourcing Services Market from 2024 to 2033?
    The biomarker discovery outsourcing services market has grown rapidly, expected to increase from $12.53 billion in 2023 to $14.58 billion in 2024, with a CAGR of 16.3%. Contributing factors include the increasing disease burden, demand for pharmaceutical R&D, a supportive regulatory environment, cost-effective solutions, research collaborations, and globalization.

    The biomarker discovery outsourcing services market is anticipated to grow to $26.85 billion by 2028 at a CAGR of 16.5%, driven by personalized medicine, AI integration, precision oncology, biomarker validation services, regulatory support, targeted therapies, and patient-centric healthcare. Trends include precision medicine adoption, technological innovations, demand for companion diagnostics, expanded drug development pipelines, applications in non-traditional disease areas, and focus on cost-effectiveness.

    Claim Your Free Sample of the Global Biomarker Discovery Outsourcing Services Market Report Today!
    https://www.thebusinessresearchcompany.com/sample.aspx?id=15741&type=smp

    What Key Factors Are Fueling the Growth of the Biomarker Discovery Outsourcing Services Market?
    The rising focus on personalized medicine is projected to propel the biomarker discovery outsourcing services market. This approach tailors medical treatments based on individual characteristics, improving healthcare outcomes. Outsourcing biomarker discovery facilitates personalized medicine advancements through tailored diagnostic solutions. For instance, the Personalized Medicine Coalition reported that the FDA approved 16 new personalized treatments for rare diseases in 2023, including seven cancer drugs. Therefore, the increasing focus on personalized medicine drives the biomarker discovery outsourcing services market.

    What Are the Major Segments of the Biomarker Discovery Outsourcing Services Market?
    1) By Type: Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, Surrogate Endpoints
    2) By Discovery Phase: Biomarker Identification, Biomarker Validation, Biomarker Profiling, Biomarker Panel Development, Biomarker Selection
    3) By Therapeutic Area: Oncology, Cardiology, Neurology, Autoimmune Diseases, Other Therapeutic Areas
    4) By End Use: Pharmaceutical Companies, Biotechnology Companies

    What New Trends Are Transforming the Biomarker Discovery Outsourcing Services Market?
    In the biomarker discovery outsourcing services market, companies are developing multiplexed biomarker assays, such as the immunoproteomic discovery platform, to improve patient outcomes. This platform merges immunology with proteomics for immune response analysis. In October 2023, Sengenics Corporation LLC, a Singapore precision medicine company, launched an immunoproteomic discovery platform for analyzing autoantibodies associated with disease.

    Order Now for Fast Delivery of Your Biomarker Discovery Outsourcing Services Market Report!
    https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

    Which Regions Are Driving Growth in the Biomarker Discovery Outsourcing Services Market?
    North America was the largest region in the biomarker discovery outsourcing services market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period.  The regions covered in the biomarker discovery outsourcing services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

    The Biomarker Discovery Outsourcing Services Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the biomarker discovery outsourcing services market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Biomarker Discovery Outsourcing Services Market Include

    1. Biomarker Discovery Outsourcing Services Market Executive Summary
    2. Biomarker Discovery Outsourcing Services Market Segments
    3. Biomarker Discovery Outsourcing Services Market Size And Template Market Growth Rate
    4.  Key Biomarker Discovery Outsourcing Services Market Trends
    5. Major Biomarker Discovery Outsourcing Services Market Drivers
    ……
    25. Key Mergers And Acquisitions In The Biomarker Discovery Outsourcing Services Market
    26. Top Biomarker Discovery Outsourcing Services Companies
    27. Biomarker Discovery Outsourcing Services Market Opportunities And Strategies
    28. Biomarker Discovery Outsourcing Services Market, Conclusions And Recommendations
    29. Appendix

    Discover Related Reports by The Business Research Company:
    Bio-Lubricants Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biolubricants-global-market-report

    Biomarkers Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biomarkers-global-market-report

    Biofertilizers Global Market Report 2024
    https://www.thebusinessresearchcompany.com/report/biofertilizers-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:
    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Biomarker Discovery Outsourcing Services Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    Biomarker Discovery Outsourcing Services Global Market Outlook 2024-2033: Size And Growth Rate Analysis

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The biomarker discovery outsourcing services market has seen rapid growth in recent years and is projected to continue this trend. In this blog, we’ll explore the current market size, future growth prospects, major trends, and the role of advanced technologies and strategic acquisitions in this dynamic industry.

    Market Size and Growth Projections

    • Rapid Growth in Recent Years:
      • In 2023, the biomarker discovery outsourcing services market was valued at $12.53 billion.
      • The market is projected to grow to $14.58 billion by 2024, representing a compound annual growth rate (CAGR) of 16.3%.
      • This growth is largely driven by increasing disease burden, rising pharmaceutical R&D demand, and the regulatory environment favoring cost-effective solutions.
    • Future Growth Prospects:
      • The market is expected to reach $26.85 billion by 2028, with a CAGR of 16.5%.
      • Growth in the forecast period will be fueled by personalized medicine, AI integration, precision oncology, and increasing demand for biomarker validation services.

    Drivers of Growth

    • Personalized Medicine Expansion:
      • The rise of personalized medicine is a significant driver for the market. Personalized medicine tailors treatments to individual patients based on their unique biological markers, improving outcomes and reducing adverse effects.
      • Outsourcing biomarker discovery supports personalized medicine by offering tailored diagnostic and therapeutic solutions.
      • For example, the FDA approved 16 new personalized treatments in 2023, including seven cancer drugs, highlighting the growing focus on this area.
    • Technological Advancements:
      • Advanced technologies, such as multiplexed biomarker assays and immunoproteomic discovery platforms, are driving innovation in the market.
      • These platforms enable the identification and analysis of proteins related to the immune response, advancing biomarker discovery and development.
      • Sengenics Corporation LLC, for instance, launched the i-Ome Discovery platform in 2023, a comprehensive tool for analyzing autoantibodies associated with disease diagnosis and therapeutic intervention.

    View More On The Biomarker Discovery Outsourcing Services Market Report 2024 – https://www.thebusinessresearchcompany.com/report/biomarker-discovery-outsourcing-services-global-market-report

    Major Market Trends

    • Increased Adoption of Precision Medicine:
      • Precision medicine is expected to see greater adoption, driving demand for biomarker discovery outsourcing services.
      • The integration of AI and machine learning (ML) in precision oncology and other fields will further propel market growth.
    • Rising Demand for Companion Diagnostics:
      • As drug development pipelines expand, there is an increasing need for companion diagnostics, which are tests that help determine the effectiveness of specific drugs for individual patients.
    • Global Market Expansion:
      • North America currently dominates the market, but Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by increasing healthcare investments and expanding pharmaceutical industries.

    Key Players and Strategic Moves

    • Major Companies in the Market:
      • Some of the leading companies in the biomarker discovery outsourcing services market include Thermo Fisher Scientific Inc., Labcorp Drug Development Inc., ICON plc, Eurofins Scientific SE, and WuXi AppTec Co. Ltd.
    • Strategic Acquisitions:
      • Companies are expanding their services and geographic reach through strategic acquisitions. For example, in July 2021, ICON plc acquired PRA Health Sciences for $12 billion. This acquisition strengthened ICON’s consulting, clinical, and commercial services portfolio and enhanced its global presence.

    Market Segmentation

    • By Type:
      • Predictive Biomarkers
      • Prognostic Biomarkers
      • Safety Biomarkers
      • Surrogate Endpoints
    • By Discovery Phase:
      • Biomarker Identification
      • Biomarker Validation
      • Biomarker Profiling
      • Biomarker Panel Development
      • Biomarker Selection
    • By Therapeutic Area:
      • Oncology
      • Cardiology
      • Neurology
      • Autoimmune Diseases
      • Other Therapeutic Areas
    • By End Use:
      • Pharmaceutical Companies
      • Biotechnology Companies

    Conclusion
    The biomarker discovery outsourcing services market is set for continued robust growth, driven by the expansion of personalized medicine, technological advancements, and strategic acquisitions. With North America leading the market and Asia-Pacific emerging as a fast-growing region, the industry is poised for significant developments that will reshape healthcare and drug development globally.

    Request A Sample Of The Global Biomarker Discovery Outsourcing Services Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=15741&type=smp